Quetiapine Tablet, Extended Release
Product Images NDC 29300-308

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 29300-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 01)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 01)
Chemical structure of quetiapine fumarate, depicting two quetiapine molecules complexed with one molecule of fumaric acid.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 02)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 02)
A Kaplan-Meier curve showing the proportion of patients with relapse over time in months. Two groups are compared: one treated with placebo (PLA, dashed line) and the other with Quetiapine extended release (QTP XR, solid line). The graph depicts relapse rates increasing over 7 months, with higher relapse proportion in the placebo group.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 03)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 03)
A line graph depicting the proportion of patients with relapse (%) over time in weeks. It compares two groups: one labeled as QTP+LIVAL and another as PLA+LIVAL. The graph shows relapse proportions increasing over time, with QTP+LIVAL group having a higher relapse rate than the PLA+LIVAL group.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 04)

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 04)
A line graph depicting the proportion of patients with relapse (%) over time in weeks. Two lines represent different groups labeled 'QTP+LIVAL' and 'PLA+LIVAL,' showing different relapse rates across approximately 100 weeks.*
FDA Label Image

Image (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 05)

FDA Label Image

Quetiapine Exended-release Tablets Usp, 50 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 06)

Quetiapine Exended-release Tablets Usp, 50 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 06)
Quetiapine Extended-Release Tablets, USP 50 mg oral tablets packaging label displaying the product name, strength, and dosing instruction of once daily. The label includes storage instructions, a warning to keep out of children\'s reach, and manufacturer information for Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), Inc. It also shows a barcode and states the package contains 60 tablets.*
FDA Label Image

Quetiapine Extended-release Tablets Usp, 150 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 07)

Quetiapine Extended-release Tablets Usp, 150 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 07)
Label for Quetiapine Extended-Release Tablets, USP 150 mg, provided by Unichem Pharmaceuticals (USA), Inc. The label includes dosage instructions (once daily), storage conditions (20°C to 25°C), and a 60-tablet bottle count. It also features the NDC code 29300-309-16 and manufacturer details for Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc.*
FDA Label Image

Quetiapine Extended-release Tablets Usp, 200 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 08)

Quetiapine Extended-release Tablets Usp, 200 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 08)
Quetiapine Extended-Release Tablets, USP 200 mg oral tablets in a 60-tablet container. The label includes storage instructions, dosage guidance of once daily, and warnings. Manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc.*
FDA Label Image

Quetiapine Extended-release Tablets, Usp, 300 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 09)

Quetiapine Extended-release Tablets, Usp, 300 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 09)
Label for Quetiapine Extended-Release Tablets, USP, 300 mg oral tablets. The label indicates a 60-tablet bottle, prescription only, from Unichem Pharmaceuticals (USA), Inc. It includes usage instructions to swallow whole once daily and storage conditions. Manufacturer information for Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA) is present, along with an NDC code 29300-311-16 and barcode.*
FDA Label Image

Quetiapine Extended-release Tablets Usp, 400 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 10)

Quetiapine Extended-release Tablets Usp, 400 mg (3ec5c4ad 8a55 4091 Ada4 4e009332a5ec 10)
Label for Quetiapine Extended-Release Tablets, USP 400 mg, tablets in a 60-count package. Manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. The label includes dosage and storage instructions, a barcode, and usage warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.